Physician profile
Robert Sedaros
NPI 1750313607
$27,551.29
in general payments reported to CMS, 2019-2025
17 companies · $2,536 in 2025
The $2,536 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $4,934 · 2021: $197 · 2022: $15.71 · 2023: $378 · 2024: $127 · 2025: $2,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,896 · Travel and Lodging: $1,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,895.52 |
| Travel and Lodging | $1,145.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $22,241.20 | 2019-2025 | Blueprint Patient Specific Instrumentation, Ortholoc 3di |
| Arthrex, INC. | $2,672.81 | 2020-2025 | |
| Zimmer Biomet Holdings, INC. | $1,718.64 | 2019-2025 | Persona |
| Smith+Nephew, INC. | $342.33 | 2019-2025 | Journey II, Real Intelligence, Legion |
| Maxx Orthopedics, INC. | $190.17 | 2019 | |
| Aesculap, INC. | $141.11 | 2021 | |
| Depuy Synthes Sales INC. | $57.42 | 2023 | Tfn-Advance, Monovisc, Orthovisc |
| Pacira Pharmaceuticals Incorporated | $32.16 | 2019-2023 | Zilretta, Iovera, Exparel |
| Catalyst Orthoscience | $25.83 | 2021 | |
| Endo Pharmaceuticals INC. | $20.58 | 2019 | |
| Endo USA, INC. | $20.14 | 2024 | Xiaflex |
| Medacta USA, INC. | $18.49 | 2025 | Spherika |
| Embody, INC. | $15.71 | 2022 | |
| Wright Medical Technology, INC. | $14.66 | 2019 | |
| Avanos Medical | $14.11 | 2023 | Trivisc Sodium Hyaluronate |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $14.02 | 2019 | |
| Bioventus LLC | $11.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sedaros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.